Creative India: tapping the full potential
India’s creative economy is large, but its untapped potential is even larger. This study provides the first reliable measure on the size of India’s creative economy, explores the many challenges faced
Intellectual Property Rights (IPR)
-
What Ails Clinical Trials Industry?
Controversies and litigations threaten to derail a sector that once saw immense potential in India. Are you getting free medicines? Have you been asked to return the empty medicine bottles? If so, contact
-
Go slow on ratifying Nagoya Protocol, say experts
Institutionalised mechanism forbenefit sharing mooted As India gets ready to ratify the Nagoya Protocol on Access and Benefit Sharing (ABS) arising from utilisation of genetic resources, scientists and Intellectual Property Rights (IPR) experts point to the dangers of opening up the country’s rich biodiversity for exploitation by foreign powers without a domestic regulatory framework in place. The first meeting of the signatories to the protocol is being held in connection with the 11{+t}{+h}Conference of Parties to the Convention on Biological Diversity which began in Hyderabad on Monday.
-
Seed freedom: a global citizens' report
<p><span id="itro1">This global citizens' report published by Navdanya, depicts concentration and restrictions in the global seed sector as a result of IPR regimes and corporate convergence. Focuses
-
Ten years of the Biological Diversity Act
As India plays host to the Convention on Biological Diversity's 11th Conference of the Parties in Hyderabad in October 2012, this article takes a closer look at the country's legislation on the subject
-
A bitter pill
The Novartis case highlights the need for innovation in the public interest. The Supreme Court has commenced final hearings on a case brought before it by the Swiss pharmaceutical company, Novartis. The
-
Open source drug discovery in practice: A case study
Open source drug discovery offers potential for developing new and inexpensive drugs to combat diseases that disproportionally affect the poor. The concept borrows two principle aspects from open source
-
Interpol wants to join the ‘fake drugs’ battle, Indian government fights shy
New Delhi The International Cri-minal Police Organisation, popularly known as Interpol, wants to assist the Indian government in its effort to clamp down on the alleged ‘fake drugs’ network in the country.
-
Panel Proposes Linking Patented Drug Prices to Per Capita Income
An inter-ministerial group tasked with regulating prices of patented medicines has recommended using a per capita income-linked reference pricing mechanism, a proposal that may reduce prices of several
-
Farmers’ patent, rights on doorstep
Ranchi, Aug. 8: Farmers of the region, always in dire need of advice on crops and registering various plant varieties, will now have access to experts in Ranchi now that a branch office of a Delhi-based
-
Prized or priced?: protection of India’s traditional knowledge related to biological resources and intellectual property
The traditional knowledge (TK) of India’s people touches many lives within the country and outside it. For the holders of TK, it is their very lives and thus valuable as is. For others who don’t live by